Cellectis

Research Cellectis (ALCLS) on Bullrun: market cap EUR 248.31M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerALCLS
• ExchangePA
• CountryFrance
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 248.31M

Valuation Snapshot

latest market cap is EUR 248.31M.

About Cellectis

Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing BALLI-01, to evaluate the safety, expansion, persistence, and clinical activities of lasme-cel in patients with r/r ALL;

Frequently asked questions

What is Cellectis's market cap?

Cellectis's market capitalization is EUR 248.31M.

What does Cellectis do?

Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.